Charles D. Burger, MD: Group 4 chronic thromboembolic PH [pulmonary hypertension], or CTEPH, is a very challenging area because it’s difficult to understand exactly why a patient goes on to develop ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, everyone, and welcome to this Medscape InDiscussion podcast. Today we're talking about chronic thromboembolic pulmonary ...

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, long-term complication of acute pulmonary embolism (APE) with a poor prognosis, if left untreated. 1,2 Most published studies report ...

A long-term analysis designed by Christian Gerges and Irene Lang at the Department of Medicine II of the University Hospital Vienna and MedUni Vienna indicates that one-third of patients with chronic ...

Lungs Heart Janssen noted that the phase 3 UNISUS study will continue as planned. Janssen has decided to stop a phase 3 study evaluating macitentan 75mg for the treatment of chronic thromboembolic ...

Please provide your email address to receive an email when new articles are posted on . As a rarer form of pulmonary hypertension, chronic thromboembolic pulmonary hypertension, or CTEPH, often ...

Suita, Japan – Chronic thromboembolic pulmonary hypertension (CTEPH) is the clinical term for high blood pressure in the lungs caused by blockages, such as clots, in the blood vessels. Although CTEPH ...

Please provide your email address to receive an email when new articles are posted on . 6-minute walk distances were shorter among patients with chronic thromboembolic pulmonary hypertension and low ...

Evidence on the safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension shows the potential for serious but well-recognised complications. In relation to efficacy: ...

Today we're talking about chronic thromboembolic pulmonary hypertension (PH). I'm Vallerie McLaughlin, professor of medicine at the University of Michigan. And I'm so excited to be joined today by ...